Mediworld 07th MAY-JUNE LR

Interview
Regaining lost motor control
Interview
“DBS is a technology that delivers small pulses of
electricity to a very specific part of the brain that can
help patients regain lost motor control,” explains Will
Rosellini, Chairman and CEO of Nexeon MedSystems
Bioelectronics is an emerging branch of medical science
dealing with combined application of the principles of
biology and electrical engineering. This is a crucial field
in medicine and has led to the development of vital
devices such as the artificial pacemaker and the plethora
of medical imaging devices that are available today.
Since electricity is a major part of the human body's
operating system, the bioelectronics field holds a lot of
promise in the coming years.
Global bioelectronics market
Global bioelectronics market is expected to grow at a
lucrative rate during the forecast period at a modest
CAGR of 12.1 per cent during 2017 – 2022, owing to the
increasing advancements in surface chemistry and in
semiconductor technology related to man-made devices
and interface of biology, and advancements in devices
and technologies that will enable applications in the
areas such as prosthetics, disease detection, and
disease prevention.
Increasing demand for diagnostic as well as monitoring
devices such as blood cardiac pacemakers, glucose level
and other implantable medical devices are likely to fuel
up bioelectronics market. Rising incidence and
prevalence rate of diabetes accompanied by growing
need to measure and observe blood glucose level is likely
“DBS works much like a pacemaker in
that an implantable battery send
small electrical signals through a
wire, but instead of the wire going to
the heart it actually goes into the
brain where it can help regulate a
malfunctioning network within the
nervous system. While DBS has been
on market for nearly three decades, it
has seen very little innovation.” - Will
Rosellini, Chairman and CEO of
Nexeon MedSystems
to positively impact the biosensors market.
Technological advancement along with increasing
innovation is expected to drive the industry growth.
The primary driver of the global bioelectronics market is,
naturally, rising demand from the healthcare sector. Due
to the increasing prevalence of several neural and
cardiac diseases, the demand for bioelectronics devices
and technology has shot up. Cancer is another
increasingly prevalent disease driving the demand for
bioelectronics globally. The higher precision offered by
bioelectronics products in comparison with the
traditional diagnostics tools is one of the major factors
propelling the global bioelectronics market.
10